Infectious Diseases - Class II Biosafety Cabinets – Understanding the Basics
View as a Web Page
News Medical
 
  Infectious Diseases Infectious Diseases logo  
  The latest infectious diseases news from News Medical  
 

Chikungunya Virus (CHIKV) Research ToolsChikungunya Virus (CHIKV) Research Tools

CHIKV has been reported in 119 countries and regions, and there is a potential for widespread outbreak. In response to the new CHIKV variants, Sino Biological quickly launched recombinant E1 and E2 proteins, as well as antibodies, to support researchers in the development of vaccines, antiviral drugs, and immunodiagnostic assays.

Discover the Research Tools
 
 
    Class II Biosafety Cabinets – Understanding the BasicsClass II Biosafety Cabinets – Understanding the Basics
 
A Class II Biosafety Cabinet (BSC) serves as the Primary Engineering Control (PEC) in providing personnel, environmental, and/or product protection against biohazards and potentially harmful agents. To ensure your laboratory or pharmacy is operating safely, utilizing the correct BSC is essential. This short eBook will help you understand the critical role BSCs play in ensuring safe operational practices and what features to look for before purchasing.
 
Download the eBook
 
 
   HIV trial points to semaglutide as a new anti-aging contenderHIV trial points to semaglutide as a new anti-aging contender
 
Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by multiple DNA methylation clocks in a randomized controlled trial. These exploratory findings suggest GLP-1 receptor agonists could impact biological aging but require further validation in broader populations.
 
   New toolkit supports hepatitis prevention and care in European prisonsNew toolkit supports hepatitis prevention and care in European prisons
 
The new toolkit is designed to support the implementation and scale-up of hepatitis B and C interventions in prisons across Europe.
 
   Identifying high risk "pathogen X" with potential to spark future pandemicsIdentifying high risk "pathogen X" with potential to spark future pandemics
 
Announcing a new article publication for Zoonoses journal. In past decades, numerous emerging infectious diseases have markedly affected global health and social-economic development.
 
   Weill Cornell Medicine leads $14.9 million effort to develop personalized HIV curesWeill Cornell Medicine leads $14.9 million effort to develop personalized HIV cures
 
A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find ways to remove latent HIV from the cells of individuals with HIV.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025